Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Correa-da Rosa
276 Reduction of Cardiovascular Disease-Associated Proteins in Blood of Psoriasis Patients After 1-Month Treatment With Tofacitinib or Etanercept
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Related publications
Discontinuation of Etanercept After Successful Treatment in Patients With Juvenile Idiopathic Arthritis
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Induction or Exacerbation of Psoriasis in Patients With Crohn's Disease Under Treatment With Anti-TNF Antibodies
Digestion
Gastroenterology
Tofacitinib for the Treatment of Psoriasis and Psoriatic Arthritis
Expert Review of Clinical Immunology
Allergy
Immunology
Comparison of Lipid and Lipid-Associated Cardiovascular Risk Marker Changes After Treatment With Tocilizumab or Adalimumab in Patients With Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
The Effect of Etanercept on Traditional Metabolic Risk Factors for Cardiovascular Disease in Patients With Rheumatoid Arthritis
Clinical Rheumatology
Medicine
Rheumatology
Pharmacokinetics of Subcutaneously Administered Etanercept in Subjects With Psoriasis
British Journal of Clinical Pharmacology
Pharmacology
Extent of Cardiovascular Risk Reduction Associated With Treatment of Isolated Systolic Hypertension
Archives of Internal Medicine
Reduction of Cardiovascular Disease Events by Worksite Hypertension Treatment.
Hypertension
Internal Medicine
Cardiovascular Disease in Patients With Psoriatic Arthritis: Correlation or Causation?
